The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids
Open accessAbstract
Abstract —Oxidation of low density lipoprotein (LDL) phospholipids containing arachidonic acid at the sn -2 position occurs when a critical concentration of “seeding molecules” derived from the lipoxygenase pathway is reached in LDL. When this critical concentration is reached, the nonenzymatic oxidation of LDL phospholipids produces a series of biologically active, oxidized phospholipids that mediate the cellular events seen in the developing fatty streak. Normal high density lipoprotein (HDL) contains at least 4 enzymes as well as apolipoproteins that can prevent the formation of the LDL-derived oxidized phospholipids or inactivate them after they are formed. In the sense that normal HDL can prevent the formation of or inactivate these inflammatory LDL-derived oxidized phospholipids, normal HDL is anti-inflammatory. HDL from mice that are genetically predisposed to diet-induced atherosclerosis became proinflammatory when the mice are fed an atherogenic diet, injected with LDL-derived oxidized phospholipids, or infected with influenza A virus. Mice that were genetically engineered to be hyperlipidemic on a chow diet and patients with coronary atherosclerosis, despite normal lipid levels, also had proinflammatory HDL. It is proposed that LDL-derived oxidized phospholipids and HDL may be part of a system of nonspecific innate immunity and that the detection of proinflammatory HDL may be a useful marker of susceptibility to atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)
Fuster, V. (1992) · New England Journal of Medicine · Cited by 1,954
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
Self-citationThe oxidation hypothesis of atherosclerosis
Witztum, J. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92346-9 · Cited by 1,389
Cited by
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Self-citationZheng, L., Nukuna, B., Brennan, M.-L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421109 · Cited by 737
Navab, M., Ananthramaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400001-jlr200 · Cited by 688
Self-citationKontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
HDL Cholesterol and Protective Factors in Atherosclerosis
Assmann, G., & Gotto, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000131512.50667.46 · Cited by 630
Ansell, B. J., Navab, M., Hama, S., Kamranpour, N., Fonarow, G., Hough, G., Rahmani, S., Mottahedeh, R., Dave, R., Reddy, S. T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103624.14436.4b · Cited by 590
Self-citationDyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
Vaziri, N. D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00099.2005 · Cited by 538
Ng, C. J., Wadleigh, D. J., Gangopadhyay, A., Hama, S., Grijalva, V. R., Navab, M., Fogelman, A. M., & Reddy, S. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105660200 · Cited by 466
Self-citationMcMahon, M., Grossman, J., FitzGerald, J., Dahlin‐Lee, E., Wallace, D. J., Thong, B. Y., Badsha, H., Kalunian, K., Charles, C., Navab, M., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21976 · Cited by 431
Self-citationNavab, M., Anantharamaiah, G. M., Hama, S., Garber, D. W., Chaddha, M., Hough, G., Lallone, R., & Fogelman, A. M. (2002) · Circulation · doi:10.1161/hc0302.103711 · Cited by 401
Self-citationOsteogenic regulation of vascular calcification: an early perspective
Vattikuti, R., & Towler, D. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00552.2003 · Cited by 397
Unraveling the complexities of the HDL lipidome
Kontush, A., Lhomme, M., & Chapman, M. J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036095 · Cited by 396
Inflammatory Reactions in the Pathogenesis of Atherosclerosis
Fan, J., & Watanabe, T. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.63 · Cited by 356
Inflammation in Atherosclerosis and Implications for Therapy
Paoletti, R., Gotto, A. M., & Hajjar, D. P. (2004) · Circulation · doi:10.1161/01.cir.0000131514.71167.2e · Cited by 349
Atheroprotective Effects of High-Density Lipoproteins
Assmann, G., & Nofer, J.-R. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152409 · Cited by 343
Reverse cholesterol transport and cholesterol efflux in atherosclerosis
Ohashi, R., Mu, H., Wang, X., Yao, Q., & Chen, C. (2005) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hci136 · Cited by 336
Navab, M., Anantharamaiah, G. M., Reddy, S. T., Hama, S., Hough, G., Grijalva, V. R., Wagner, A. C., Frank, J. S., Datta, G., Garber, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134275.90823.87 · Cited by 323
Self-citationHolvoet, P., Kritchevsky, S. B., Tracy, R. P., Mertens, A., Rubin, S. M., Butler, J., Goodpaster, B., & Harris, T. B. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1068 · Cited by 318
Tselepis, A. D., & John Chapman, M. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)00045-4 · Cited by 314
Choy, E., Ganeshalingam, K., Semb, A. G., Szekanecz, Z., & Nurmohamed, M. (2014) · Rheumatology · doi:10.1093/rheumatology/keu224 · Cited by 303
Rosenson, R. S., Otvos, J. D., & Freedman, D. S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02427-x · Cited by 293
Ali, K. M., Wonnerth, A., Huber, K., & Wojta, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02081.x · Cited by 292
High-Density Lipoprotein Function
Ansell, B. J., Watson, K. E., Fogelman, A. M., Navab, M., & Fonarow, G. C. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.080 · Cited by 285
Self-citationChapman, M. J., Assmann, G., Fruchart, J.-C., Shepherd, J., & Sirtori, C. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125004402 · Cited by 257
Changes in the concentration and composition of plasma lipoproteins during the acute phase response
Carpentier, Y. A., & Scruel, O. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200203000-00006 · Cited by 148
Verreth, W., De Keyzer, D., Pelat, M., Verhamme, P., Ganame, J., Bielicki, J. K., Mertens, A., Quarck, R., Benhabilès, N., Marguerie, G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000147614.85888.7a · Cited by 131
Morris, G., Puri, B. K., Bortolasci, C. C., Carvalho, A., Berk, M., Walder, K., Moreira, E. G., & Maes, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.037 · Cited by 84
Metadata
- Authors
- Navab, M., Berliner, J. A., Subbanagounder, G., Hama, S., Lusis, A. J., Castellani, L. W., Reddy, S., Shih, D., Shi, W., Watson, A. D., Van Lenten, B. J., Vora, D., & Fogelman, A. M.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2001-04
- Volume
- 21
- Issue
- 4
- Pages
- 481-488
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2122896036
- Cited by
- 442
- References
- 82
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.